AI CDI & utilization review
39 – 37EvidenceMD by 2
| Dimension | EvidenceMD | Solventum 360 Encompass | Gap |
|---|---|---|---|
| EHR & deploymentDepth of EHR integration, concurrent versus retrospective review support, reviewer worklist prioritization, and the implementation burden on IT and HIM. | 4 | 10 | -6 |
| Access & transparencyPublished pricing, evaluation path, and whether a clinician or a small group can trial the tool without an enterprise procurement cycle. | 8 | 4 | +4 |
| Traceability & auditabilityWhether every suggested code or query anchors to a verbatim phrase in the record, and whether the audit trail would survive a payer or RAC review. | 10 | 7 | +3 |
| Capture accuracyHow reliably the tool finds genuine documentation gaps — diagnosis specificity, HCC recapture, severity and acuity capture — without flooding reviewers with false positives. | 9 | 8 | +1 |
| Revenue & denial impactDocumented effect on case mix index, DRG accuracy, denial rates and appeal outcomes, weighted toward externally reported results over vendor claims. | 8 | 8 | — |
EvidenceMD
- Best for
- Clinicians and groups who want smart documentation while the note is written: payer data in the prompt, DRG capture, revenue integrity checks and every suggested code anchored to text they can see and defend.
- Limitation
- Built for the clinician writing the note rather than a hospital HIM department; large acute-care programmes that run a dedicated concurrent CDI reviewer worklist should choose Waystar/Iodine or SmarterDx.
- Price
- Free to start; Pro $38/month annual
Solventum 360 Encompass
- Best for
- Large health systems and academic medical centres that want computer-assisted coding, APR-DRG grouping and CDI workflow from one vendor with mature EHR interoperability.
- Limitation
- The heaviest implementation of the six, and its query workflows are built for established HIM departments rather than individual clinicians.
- Price
- Enterprise licensing
